Document is current
Any future updates will be listed below
-
Authors
Borghetti, Paolo https://orcid.org/0000-0001-7275-7908
Imbrescia, Jessica
Volpi, Giulia
Scotti, Vieri
Aquilano, Michele
Bruni, Alessio
Franceschini, Davide
Ursino, Stefano
Ciammella, Patrizia
Piperno, Gaia
Taraborrelli, Maria
Magrini, Stefano Maria
-
Funding
Funding for this research was provided by:
AstraZeneca Italy
- License Information
-
More Information
Article History
Received: 22 December 2021
Accepted: 14 June 2022
First Online: 16 July 2022
Declarations
:
: The study was approved by the Ethics Committee of the National Authorities when required for retrospective studies.
: Not applicable.
: Aquilano Michele: no conflict of interests. Bruni Alessio: AstraZeneca (travel grants, conference sponsorship, unconditioned editorial support), MSD (travel grants, conference sponsorship), Astellas (conference sponsorship, travel grants), Ferring Pharmaceutical (conference sponsorship, travel grants), Ipsen (conference sponsorship, travel grants), Janssen (conference sponsorship, travel grants). Borghetti Paolo: AstraZeneca (conference sponsorship). Ciammella Patrizia: no conflict of interests. Imbrescia Jessica: no conflict of interests. Franceschini Davide: AstraZeneca (Advisory board and Speakers’ Bureau). Magrini Stefano Maria: no conflict of interests. Piperno Gaia: no conflict of interests. Scotti Vieri: Advidsory boards e speaker's fee for AstraZeneca. Taraborrelli Maria: no conflict of interests. Ursino Stefano: Travel and congresses grants (Merck Serono), Congress and courses support grants (Merck Serono; Nestlè; Kyowakirin; Astra Zeneca), Meeting Honoraria (Cliningen Specialty Pharmaceuticals; Astra Zeneca). Volpi Giulia: no conflict of interests.
